{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:17:20Z","timestamp":1793657840319,"version":"4.5.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004325","name":"Astrazeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s12325-020-01444-5","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T18:05:51Z","timestamp":1595873151000},"page":"4190-4208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":110,"title":["Asthma-Related Health Outcomes Associated with Short-Acting \u03b22-Agonist Inhaler Use: An Observational UK Study as Part of the SABINA Global Program"],"prefix":"10.1007","volume":"37","author":[{"given":"Chloe I.","family":"Bloom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"Arnetorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Coulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf J. P.","family":"van der Valk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K.","family":"Quint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,27]]},"reference":[{"key":"1444_CR1","doi-asserted-by":"publisher","first-page":"1802130","DOI":"10.1183\/13993003.02130-2018","volume":"53","author":"CI Bloom","year":"2019","unstructured":"Bloom CI, Saglani S, Feary J, Jarvis D, Quint JK. Changing prevalence of current asthma and inhaled corticosteroid treatment in the UK: population-based cohort 2006\u20132016. Eur Respir J. 2019;53:1802130.","journal-title":"Eur Respir J"},{"key":"1444_CR2","unstructured":"Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention; 2019. https:\/\/ginasthma.org\/. Accessed 13 Jan 2020."},{"key":"1444_CR3","unstructured":"British Thoracic Society. Scottish Intercollegiate Guidelines Network: British Guideline on the Management of Asthma; 2019. https:\/\/www.brit-thoracic.org.uk\/quality-improvement\/guidelines\/asthma\/. Accessed 13 Jan 2020."},{"key":"1444_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(16)31399-X","volume":"389","author":"HK Reddel","year":"2017","unstructured":"Reddel HK, Busse WW, Pedersen S, et al. Should recommendations about starting inhaled corticosteroid treatment for mild asthma be based on symptom frequency: a post-hoc efficacy analysis of the START study. Lancet. 2017;389:157\u201366.","journal-title":"Lancet"},{"key":"1444_CR5","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1056\/NEJMoa1715274","volume":"378","author":"PM O\u2019Byrne","year":"2018","unstructured":"O\u2019Byrne PM, FitzGerald JM, Bateman ED, et al. Inhaled combined budesonide-formoterol as needed in mild asthma. N Engl J Med. 2018;378:1865\u201376.","journal-title":"N Engl J Med"},{"key":"1444_CR6","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1056\/NEJMoa1715275","volume":"378","author":"ED Bateman","year":"2018","unstructured":"Bateman ED, Reddel HK, O\u2019Byrne PM, et al. As-needed budesonide-formoterol versus maintenance budesonide in mild asthma. N Engl J Med. 2018;378:1877\u201387.","journal-title":"N Engl J Med"},{"key":"1444_CR7","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1053\/rmed.2000.0820","volume":"94","author":"RJ Hancox","year":"2000","unstructured":"Hancox RJ, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Taylor DR. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment. Respir Med. 2000;94:767\u201371.","journal-title":"Respir Med"},{"key":"1444_CR8","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1164\/ajrccm.149.3.8118625","volume":"149","author":"S Suissa","year":"1994","unstructured":"Suissa S, Ernst P, Boivin JF, et al. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med. 1994;149:604\u201310.","journal-title":"Am J Respir Crit Care Med"},{"key":"1444_CR9","doi-asserted-by":"publisher","first-page":"1901046","DOI":"10.1183\/13993003.01046-2019","volume":"53","author":"HK Reddel","year":"2019","unstructured":"Reddel HK, FitzGerald JM, Bateman ED, et al. GINA 2019: a fundamental change in asthma management. Eur Respir J. 2019;53:1901046.","journal-title":"Eur Respir J"},{"key":"1444_CR10","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1056\/NEJMoa1901963","volume":"380","author":"R Beasley","year":"2019","unstructured":"Beasley R, Holliday M, Reddel HK, et al. Controlled trial of budesonide-formoterol as needed for mild asthma. N Engl J Med. 2019;380:2020\u201330.","journal-title":"N Engl J Med"},{"key":"1444_CR11","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(19)31948-8","volume":"394","author":"J Hardy","year":"2019","unstructured":"Hardy J, Baggott C, Fingleton J, et al. Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial. Lancet. 2019;394:919\u201328.","journal-title":"Lancet"},{"key":"1444_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.rmed.2017.08.014","volume":"131","author":"JM FitzGerald","year":"2017","unstructured":"FitzGerald JM, Tavakoli H, Lynd LD, Al Efraij K, Sadatsafavi M. The impact of inappropriate use of short acting beta agonists in asthma. Respir Med. 2017;131:135\u201340.","journal-title":"Respir Med"},{"key":"1444_CR13","first-page":"1124","volume":"21","author":"T Makhinova","year":"2015","unstructured":"Makhinova T, Barner JC, Richards KM, Rascati KL. Asthma controller medication adherence, risk of exacerbation, and use of rescue agents among Texas Medicaid patients with persistent asthma. J Manag Care Spec Pharm. 2015;21:1124\u201332.","journal-title":"J Manag Care Spec Pharm"},{"key":"1444_CR14","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jaip.2013.04.008","volume":"1","author":"M Patel","year":"2013","unstructured":"Patel M, Pilcher J, Munro C, et al. Short-acting \u03b2-agonist use as a marker of current asthma control. J Allergy Clin Immunol Pract. 2013;1:370\u20137.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1444_CR15","first-page":"1242","volume":"127","author":"A Senthilselvan","year":"2005","unstructured":"Senthilselvan A, Lawson JA, Rennie DC, Dosman JA. Regular use of corticosteroids and low use of short-acting beta2-agonists can reduce asthma hospitalization. Chest. 2005;127:1242\u201351.","journal-title":"Chest"},{"key":"1444_CR16","first-page":"19","volume":"17","author":"HS Silver","year":"2011","unstructured":"Silver HS, Blanchette CM, Kamble S, et al. Relationship between short-acting \u03b22-adrenergic agonist use and healthcare costs. Am J Manag Care. 2011;17:19\u201327.","journal-title":"Am J Manag Care"},{"key":"1444_CR17","doi-asserted-by":"publisher","first-page":"16049","DOI":"10.1038\/npjpcrm.2016.49","volume":"26","author":"SA Hull","year":"2016","unstructured":"Hull SA, McKibben S, Homer K, Taylor SJ, Pike K, Griffiths C. Asthma prescribing, ethnicity and risk of hospital admission: an analysis of 35,864 linked primary and secondary care records in East London. NPJ Prim Care Respir Med. 2016;26:16049.","journal-title":"NPJ Prim Care Respir Med"},{"key":"1444_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.anai.2012.08.014","volume":"109","author":"RH Stanford","year":"2012","unstructured":"Stanford RH, Shah MB, D\u2019Souza AO, Dhamane AD, Schatz M. Short-acting \u03b2-agonist use and its ability to predict future asthma-related outcomes. Ann Allergy Asthma Immunol. 2012;109:403\u20137.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1444_CR19","doi-asserted-by":"publisher","first-page":"1701103","DOI":"10.1183\/13993003.01103-2017","volume":"50","author":"PM O\u2019Byrne","year":"2017","unstructured":"O\u2019Byrne PM, Jenkins C, Bateman ED. The paradoxes of asthma management: time for a new approach? Eur Respir J. 2017;50:1701103.","journal-title":"Eur Respir J"},{"key":"1444_CR20","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S0140-6736(17)30879-6","volume":"391","author":"ID Pavord","year":"2018","unstructured":"Pavord ID, Beasley R, Agusti A, et al. After asthma: redefining airways diseases. Lancet. 2018;391:350\u2013400.","journal-title":"Lancet"},{"key":"1444_CR21","doi-asserted-by":"publisher","first-page":"1901858","DOI":"10.1183\/13993003.01858-2019","volume":"55","author":"CS Cabrera","year":"2020","unstructured":"Cabrera CS, Nan C, Lindarck N, Beekman MJ, Arnetorp S, van der Valk RJ. SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting \u03b22-agonist use in asthma. Eur Respir J. 2020;55:1901858.","journal-title":"Eur Respir J"},{"key":"1444_CR22","unstructured":"Clinical Practice Research DataLink (CPRD). https:\/\/www.cprd.com\/home. Accessed 13 Jan 2020."},{"key":"1444_CR23","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/ije\/dyv098","volume":"44","author":"E Herrett","year":"2015","unstructured":"Herrett E, Gallagher AM, Bhaskaran K, et al. Data resource profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol. 2015;44:827\u201336.","journal-title":"Int J Epidemiol"},{"key":"1444_CR24","doi-asserted-by":"publisher","first-page":"e017474","DOI":"10.1136\/bmjopen-2017-017474","volume":"7","author":"F Nissen","year":"2017","unstructured":"Nissen F, Morales DR, Mullerova H, Smeeth L, Douglas IJ, Quint JK. Validation of asthma recording in the Clinical Practice Research Datalink (CPRD). BMJ Open. 2017;7:e017474.","journal-title":"BMJ Open"},{"key":"1444_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1136\/thoraxjnl-2017-210650","volume":"73","author":"CI Bloom","year":"2018","unstructured":"Bloom CI, Nissen F, Douglas IJ, Smeeth L, Cullinan P, Quint JK. Exacerbation risk and characterisation of the UK\u2019s asthma population from infants to old age. Thorax. 2018;73:313\u201320.","journal-title":"Thorax"},{"key":"1444_CR26","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1164\/rccm.201808-1516OC","volume":"199","author":"CI Bloom","year":"2019","unstructured":"Bloom CI, Palmer T, Feary J, Quint JK, Cullinan P. Exacerbation patterns in adults with asthma in England. A population-based study. Am J Resp Crit Care Med. 2019;199:446\u201353.","journal-title":"Am J Resp Crit Care Med."},{"key":"1444_CR27","unstructured":"British Thoracic Society. Scottish Intercollegiate Guidelines Network: British guideline on the management of asthma; 2016. https:\/\/www.brit-thoracic.org.uk\/document-library\/guidelines\/asthma\/btssign-asthma-guideline-2016\/. Accessed 13 Jan 2020."},{"issue":"8 Suppl 3","key":"1444_CR28","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1097\/MLR.0b013e31829b1d2a","volume":"51","author":"MA Raebel","year":"2013","unstructured":"Raebel MA, Schmittdiel J, Karter AJ, Konieczny JL, Steiner JF. Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases. Med Care. 2013;51(8 Suppl 3):S11\u201321.","journal-title":"Med Care"},{"key":"1444_CR29","doi-asserted-by":"publisher","first-page":"e005540","DOI":"10.1136\/bmjopen-2014-005540","volume":"4","author":"JK Quint","year":"2014","unstructured":"Quint JK, M\u00fcllerova H, DiSantostefano RL, et al. Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD). BMJ Open. 2014;4:e005540.","journal-title":"BMJ Open"},{"key":"1444_CR30","doi-asserted-by":"publisher","first-page":"e775","DOI":"10.3399\/bjgp18X699389","volume":"68","author":"F Nissen","year":"2018","unstructured":"Nissen F, Morales DR, Mullerova H, et al. Concomitant diagnosis of asthma and COPD: a quantitative study in UK primary care. Br J Gen Pract. 2018;68:e775\u2013e782.","journal-title":"Br J Gen Pract"},{"key":"1444_CR31","unstructured":"Department for Communities and Local Government.\u00a0The English indices of deprivation 2015: statistical release;\u00a02015. https:\/\/www.gov.uk\/government\/statistics\/english-indices-of-deprivation-2015. Accessed 24 July 2020."},{"key":"1444_CR32","unstructured":"Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention; 2017. https:\/\/ginasthma.org\/archived-reports\/. Accessed 27 Feb 2020."},{"key":"1444_CR33","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1164\/ajrccm.164.8.2104102","volume":"164","author":"PM O\u2019Byrne","year":"2001","unstructured":"O\u2019Byrne PM, Barnes PJ, Rodriguez-Roisin R, et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med. 2001;164:1392\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"1444_CR34","doi-asserted-by":"publisher","first-page":"14009","DOI":"10.1038\/npjpcrm.2014.9","volume":"24","author":"D Price","year":"2014","unstructured":"Price D, Fletcher M, van der Molen T. Asthma control and management in 8000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir Med. 2014;24:14009.","journal-title":"NPJ Prim Care Respir Med"},{"key":"1444_CR35","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12890-017-0409-3","volume":"17","author":"RY Suruki","year":"2017","unstructured":"Suruki RY, Daugherty JB, Boudiaf N, Albers FC. The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA. BMC Pulm Med. 2017;17:74.","journal-title":"BMC Pulm Med"},{"key":"1444_CR36","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1136\/thoraxjnl-2018-212723","volume":"74","author":"S Gonem","year":"2019","unstructured":"Gonem S, Cumella A, Richardson M. Asthma admission rates and patterns of salbutamol and inhaled corticosteroid prescribing in England from 2013 to 2017. Thorax. 2019;74:705\u20136.","journal-title":"Thorax"},{"key":"1444_CR37","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2147\/PPA.S234651","volume":"14","author":"S Amin","year":"2020","unstructured":"Amin S, Soliman M, McIvor A, Cave A, Cabrera C. Understanding patient perspectives on medication adherence in asthma: a targeted review of qualitative studies. Patient Prefer Adherence. 2020;14:541\u201351.","journal-title":"Patient Prefer Adherence"},{"issue":"suppl 63","key":"1444_CR38","first-page":"PA2565","volume":"54","author":"C Bloom","year":"2019","unstructured":"Bloom C, Quint J, Cabrera C. SABA and ICS use among mild asthma patients in UK primary care. Eur Respir J. 2019;54(suppl 63):PA2565.","journal-title":"Eur Respir J."},{"key":"1444_CR39","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40413-018-0209-0","volume":"11","author":"R Merchant","year":"2018","unstructured":"Merchant R, Szefler SJ, Bender BG, et al. Impact of a digital health intervention on asthma resource utilization. World Allergy Organ. 2018;11:28.","journal-title":"World Allergy Organ"},{"key":"1444_CR40","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.anai.2017.08.002","volume":"119","author":"MA Barrett","year":"2017","unstructured":"Barrett MA, Humblet O, Marcus JE, et al. Effect of a mobile health, sensor-driven asthma management platform on asthma control. Ann Allergy Asthma Immunol. 2017;119:415\u201321.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1444_CR41","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10654-018-0442-4","volume":"34","author":"S Padmanabhan","year":"2019","unstructured":"Padmanabhan S, Carty L, Cameron E, Ghosh RE, Williams R, Strongman H. Approach to record linkage of primary care data from Clinical Practice Research Datalink to other health-related patient data: overview and implications. Eur J Epidemiol. 2019;34:91\u20139.","journal-title":"Eur J Epidemiol"},{"key":"1444_CR42","unstructured":"National Health Service (NHS). Salbutamol inhaler. https:\/\/www.nhs.uk\/medicines\/salbutamol-inhaler\/. Accessed 05 June 2020."},{"key":"1444_CR43","doi-asserted-by":"publisher","first-page":"16076","DOI":"10.1038\/npjpcrm.2016.76","volume":"26","author":"M Belhassen","year":"2016","unstructured":"Belhassen M, Nibber A, Van Ganse E, et al. Inappropriate asthma therapy-a tale of two countries: a parallel population-based cohort study. NPJ Prim Care Respir Med. 2016;26:16076.","journal-title":"NPJ Prim Care Respir Med"},{"key":"1444_CR44","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1136\/adc.2010.206268","volume":"97","author":"H Elkout","year":"2012","unstructured":"Elkout H, Helms PJ, Simpson CR, McLay JS. Changes in primary care prescribing patterns for paediatric asthma: a prescribing database analysis. Arch Dis Child. 2012;97:521\u20135.","journal-title":"Arch Dis Child"},{"key":"1444_CR45","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/j.jaci.2013.10.028","volume":"133","author":"JF Slejko","year":"2014","unstructured":"Slejko JF, Ghushchyan VH, Sucher B, et al. Asthma control in the United States, 2008\u20132010: indicators of poor asthma control. J Allergy Clin Immunol. 2014;133:1579\u201387.","journal-title":"J Allergy Clin Immunol"},{"key":"1444_CR46","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1007\/s12325-020-01233-0","volume":"37","author":"C Janson","year":"2020","unstructured":"Janson C, Menzies-Gow A, Nan C, et al. SABINA: an overview of short-acting \u03b22-agonist use in asthma in European countries. Adv Ther. 2020;37:1124\u201335.","journal-title":"Adv Ther."},{"key":"1444_CR47","doi-asserted-by":"publisher","first-page":"1901872","DOI":"10.1183\/13993003.01872-2019","volume":"55","author":"B Nwaru","year":"2020","unstructured":"Nwaru B, Ekstr\u00f6m M, Hasvold P, Wiklund F, Telg G, Janson C. Overuse of short-acting \u03b22-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme. Eur Respir J. 2020;55:1901872.","journal-title":"Eur Respir J"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01444-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-020-01444-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01444-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T23:22:25Z","timestamp":1627341745000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-020-01444-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,27]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1444"],"URL":"https:\/\/doi.org\/10.1007\/s12325-020-01444-5","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,27]]},"assertion":[{"value":"5 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}